Acadia Pharmaceuticals | ACAD - 员工总数

金融业

USD 20.59

USD 1.74B

现金及等价物

USD 956.47M

USD 28.32M

USD 1.22B

USD 361.44M

USD 50.79M

USD 37.84M

USD -1.62M

653

EPS每股收益

USD 0.18

股本和储备

USD 1.31B

USD 279.64M

债务利息支出

USD 0

USD 8.06M

USD 0

USD 3.43B

USD 31.5M

USD 270.12M

USD 37.84M

普通股股本

USD 171.09M

11.33

USD 46.47M

USD 307.96M

销售和管理费用

USD 148.57M

USD 108.67M

贸易债权人

USD 44.57M

应收帐款人

USD 166.33M

	员工	更改		日
Acadia Pharmaceuticals	653		56	2024-12
ALKERMES	1.8K		300	2024-12
Alnylam Pharmaceuticals	2.23K		130	2024-12
Biogen	7.6K		35	2024-12
BioMarin Pharmaceutical	3.04K		361	2024-12
Bristol-Myers Squibb	34.1K		0	2024-12
Cara Therapeutics	55		51	2023-12
Corcept Therapeutics	500		148	2024-12
Cytokinetics	498		75	2024-12
Eisai	13.51K		2.44K	2025-12
Eli Lilly	47K		4K	2024-12
Incyte	2.62K		93	2024-12
J&J	138.1K		6.2K	2024-12
Moderna	5.8K		200	2024-12
Neurocrine Biosciences	1.8K		400	2024-12
Pfizer	81K		7K	2024-12
Prothena	163		10	2024-12
PTC Therapeutics	939		49	2024-12
Sarepta Therapeutics	1.37K		58	2024-12
Ultragenyx Pharmaceutical	1.29K		18	2024-12
Vanda Pharmaceuticals	203		87	2023-12
Vertex Pharmaceuticals	6.1K		700	2024-12